Dose Reduction of Ibrutinib in Chronic Lymphocytic Leukemia: Long-Term Outcomes from a Real-World Single-Center Experience. Mediterr J Hematol Infect Dis 2026, 18 (1), e2026090. https://doi.org/10.4084/MJHID.2026.090.